Delivery Order SPE2DB25D3108-SPE2DB25FPDHK
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,370.39 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on September 16, 2025, with an ultimate completion date of September 17, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation. The award represents a single delivery transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $17,804.46 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Vaxneuvance 0.5 mL syringes. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 22, 2025, and will be performed in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime...
- The Defense Logistics Agency awarded a $6,512.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,740.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes on August 19, 2025, with an ultimate completion date of August 20, 2025. This contract utilized firm fixed price pricing and was competitively awarded without any set-aside designation. The product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes valued at $1,370.34 on August 4, 2025, with completion scheduled for August 5, 2025. This firm fixed-price contract represents a non-competitive set-aside and will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,301.55 to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Vaxneuvance 0.5 ML syringes. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The...
- The Defense Logistics Agency awarded a delivery order valued at $17,442.92 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes. This firm fixed-price contract, issued on May 19, 2025, with an ultimate completion date of May 20, 2025, represents a competitively awarded non-set-aside procurement. The products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and distribution operations. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,345.59 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes. This competitively awarded, firm fixed-price delivery order was issued on August 21, 2025, with an ultimate completion date of August 22, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $46,657.70 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 ML syringes on September 15, 2025, with completion scheduled for September 16, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $58,226.32 to AmerisourceBergen Drug Corp for the supply of Vaxneuvance 0.5 mL syringes. This firm fixed-price contract, issued on July 31, 2025, represents a non-set-aside award made through open competition. The work will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 1, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB25D3108Indefinite Delivery Contract
- SPE2DB25D3108-SPE2DB25FPDHKDelivery Order
The Defense Logistics Agency (DLA) awarded a $3,879.96 delivery order to AmerisourceBergen Drug Corp for Vaxneuvance 0.5 ML syringes, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly supporting military and veteran healthcare systems. As a major prime contractor within the DLA's medical supply chain, the company supplies a comprehensive range of pharmaceutical products, medical devices, and vaccines to support Defense Health Agency operations and other government healthcare systems. The Vaxneuvance vaccine delivery fulfills the military's ongoing immunization requirements and demonstrates the contractor's role in supporting military medical readiness through the DLA's pharmaceutical acquisition programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 7/14/25 |